Cargando…
A Gene Signature for Predicting Outcome in Patients with Basal-like Breast Cancer
Basal-like breast cancer is a molecular subtype of breast cancer with a poor prognosis. Follow-up studies of long-term outcome in these patients, demonstrates they can be separated into two clinical groups: those who succumb to their disease within the first 5 years and those expected to show excell...
Autores principales: | Hallett, Robin M., Dvorkin-Gheva, Anna, Bane, Anita, Hassell, John A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259129/ https://www.ncbi.nlm.nih.gov/pubmed/22355741 http://dx.doi.org/10.1038/srep00227 |
Ejemplares similares
-
Identification and evaluation of network modules for the prognosis of basal-like breast cancer
por: Hallett, Robin M., et al.
Publicado: (2015) -
Claudin-Low Breast Cancer; Clinical & Pathological Characteristics
por: Dias, Kay, et al.
Publicado: (2017) -
An algorithm to discover gene signatures with predictive potential
por: Hallett, Robin M, et al.
Publicado: (2010) -
Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts
por: Gwynne, William D, et al.
Publicado: (2017) -
Hormone Receptor and ERBB2 Status in Gene Expression Profiles of Human Breast Tumor Samples
por: Dvorkin-Gheva, Anna, et al.
Publicado: (2011)